Sequencing Consumables

Global Sequencing Consumables Market to Reach US$26.6 Billion by 2030

The global market for Sequencing Consumables estimated at US$8.2 Billion in the year 2024, is expected to reach US$26.6 Billion by 2030, growing at a CAGR of 21.6% over the analysis period 2024-2030. Kits, one of the segments analyzed in the report, is expected to record a 23.6% CAGR and reach US$18.3 Billion by the end of the analysis period. Growth in the Reagents segment is estimated at 17.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 29.2% CAGR

The Sequencing Consumables market in the U.S. is estimated at US$2.2 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.4 Billion by the year 2030 trailing a CAGR of 29.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.0% and 19.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 18.1% CAGR.

Global Sequencing Consumables Market – Key Trends & Drivers Summarized

Is Next-Generation Sequencing Fueling an Unprecedented Rise in Consumables Demand?
The widespread adoption of next-generation sequencing (NGS) platforms across research, clinical, and industrial domains has significantly amplified the demand for sequencing consumables worldwide. Sequencing consumables – which include reagents, flow cells, kits, enzymes, and other single-use items necessary for sequencing workflows – form a critical backbone of the genomic value chain. As the throughput, accuracy, and accessibility of sequencing technologies improve, consumable utilization scales exponentially, driven by the sheer volume of sequencing tests being performed across a growing array of applications. In research, expanding large-scale genomic studies such as population genetics, oncology, epigenetics, and microbiome analyses are consuming vast quantities of high-fidelity sequencing kits and reagents. Additionally, clinical sequencing is gaining traction due to the increasing emphasis on personalized medicine, leading to a rise in diagnostic sequencing for cancer, rare diseases, infectious disease profiling, and pharmacogenomics – all requiring specialized, clinical-grade consumables. Each of these use cases brings unique requirements for quality, sensitivity, and processing speed, prompting a surge in both general-purpose and application-specific consumables. Furthermore, the rapid pace of innovation in sequencing instrumentation is leading to constant iterations and upgrades in compatible consumables, adding layers of complexity and fueling recurrent demand.

How Are Automation and Workflow Optimization Redefining Product Development?
Advancements in laboratory automation and integrated sequencing workflows have significantly altered the expectations surrounding consumable products. In high-throughput settings, whether in biopharma R&D, academic labs, or commercial sequencing service providers, there is an increasing preference for consumables that are optimized for speed, consistency, and compatibility with automated systems. This shift is particularly visible in the design of pre-filled reagent cartridges, ready-to-use sample prep kits, and streamlined library preparation reagents that reduce human error and hands-on time. Manufacturers are also innovating in packaging formats, reagent stability, and temperature tolerance, catering to the operational needs of decentralized sequencing environments such as clinical labs, mobile testing units, and smaller research facilities. Moreover, single-cell sequencing, spatial transcriptomics, and multi-omics approaches are ushering in specialized consumable formats with ultra-high sensitivity and specificity. These innovations are critical in supporting emerging use cases like precision oncology, neurogenetics, and pathogen surveillance. The move toward end-to-end workflow solutions has made sequencing instrument manufacturers double down on proprietary consumables, locking users into specific ecosystems while ensuring optimal performance – a trend that, although controversial, is proving lucrative and strategically advantageous.

Can Global Disparities and Supply Chain Dynamics Influence Market Momentum?
Geographic disparities in research funding, healthcare infrastructure, and regulatory frameworks have created uneven patterns in sequencing consumables adoption. North America continues to lead due to robust investments in biomedical research, favorable reimbursement for genetic testing, and the concentration of genomics firms and sequencing technology leaders. Europe follows closely with extensive precision medicine initiatives and public-private partnerships driving uptake. Meanwhile, the Asia-Pacific region is emerging as a high-growth zone, fueled by expanding genomic programs in China, India, and Japan, alongside improvements in diagnostic infrastructure and local manufacturing capabilities. However, supply chain constraints – exacerbated by geopolitical tensions, pandemic-related disruptions, and logistics limitations – have occasionally hindered the timely availability of critical consumables. The market has responded with efforts to regionalize manufacturing, enhance inventory resilience, and diversify supplier networks. Environmental concerns surrounding single-use plastics and hazardous chemical waste in consumables are also prompting industry players to explore greener alternatives and sustainable production models. In regions with cost-sensitive markets, demand is growing for affordable, modular consumable options that balance performance with accessibility, paving the way for tiered product lines and localized pricing strategies.

What’s Driving the Surging Momentum in the Sequencing Consumables Market?
The growth in the sequencing consumables market is driven by several factors directly tied to technology evolution, end-user expansion, and changing consumption patterns. First, the increasing global adoption of high-throughput sequencers, particularly benchtop and clinical-grade platforms, is pushing up routine consumable usage in both core and satellite labs. Second, the emergence of novel sequencing techniques – including long-read, nanopore, and single-molecule sequencing – is generating demand for new categories of specialized reagents and chemistry kits tailored to these platforms. Third, the diversification of sequencing applications across agriculture, food safety, forensics, and veterinary sciences is creating new end-use verticals that rely heavily on consumables for sample prep, amplification, and sequencing. Fourth, the growing prevalence of decentralized testing models and point-of-care sequencing, particularly in infectious disease detection and newborn screening, is increasing the need for portable, stable, and user-friendly consumable formats. Fifth, end-users are demanding higher throughput and reproducibility, leading to increased preference for pre-validated, automated-ready consumables compatible with integrated lab ecosystems. Finally, competitive dynamics among sequencing system manufacturers have intensified, with consumables serving as a high-margin, recurring revenue stream – prompting aggressive strategies around proprietary product ecosystems, subscription models, and value-added service bundles. Together, these factors are cementing sequencing consumables not just as supporting elements but as central revenue and innovation drivers within the broader genomics market landscape.

SCOPE OF STUDY:

The report analyzes the Sequencing Consumables market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Kits, Reagents, Accessories); Application (Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics, Others); End-Use (Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes, Others)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Agilent Technologies, Inc.
• Analytik Jena AG
• Beckman Coulter, Inc.
• BGI Genomics
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Eurofins Genomics
• F. Hoffmann-La Roche Ltd.
• GATC Biotech (Eurofins Genomics)
• GenScript Biotech Corporation
• Illumina, Inc.
• Integrated DNA Technologies, Inc.
• Invitrogen (Thermo Fisher Scientific)
• LGC Biosearch Technologies
• Lucigen Corporation
• Macrogen Inc.
• MGI Tech Co., Ltd.
• Micronit
• Millipore Sigma
• New England Biolabs, Inc.
• Nugen Technologies, Inc.
• Oxford Nanopore Technologies Ltd.
• Pacific Biosciences of California, Inc.
• PerkinElmer, Inc.
• Promega Corporation
• QIAGEN N.V.
• Swift Biosciences, Inc.
• Takara Bio Inc.
• Thermo Fisher Scientific, Inc.
• Zymo Research Corporation

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.